Symposium on Contrave

Kwangdong Pharmaceutical Vice Chairman and CEO Choi Sung-won delivers a congratulatory speech to a symposium marking the introduction to Korea of Contrave, an anti-obesity drug, at the Grand InterContinental Seoul Parnas in southern Seoul, Wednesday. Over 700 medical doctors and scholars, including George Washington University School of Medicine Professor Scott Kahan, attended the symposium to discuss the efficacy of Contrave which was approved by the U.S. Food and Drug Administration (FDA). Under a distributorship agreement with the U.S.-based biopharmaceutical company Orexigen Therapeutics, Kwangdong began marketing Contrave this month. / Courtesy of Kwangdong Pharmaceutical